Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208624

VIEKIRA XR (DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR)
EQ 200MG BASE;8.33MG;50MG;33.33MG Marketing Status: Prescription

Active Ingredient: DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
Proprietary Name: VIEKIRA XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 200MG BASE;8.33MG;50MG;33.33MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N208624
Product Number: 001
Approval Date: Jul 22, 2016
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English